Cargando…
Comparison of the Efficacy and Safety of Bexarotene and Photo(Chemo)Therapy Combination Therapy and Bexarotene Monotherapy for Cutaneous T-Cell Lymphoma
INTRODUCTION: Cutaneous T-cell lymphoma (CTCL) is a chronic condition with low malignancy. The combined use of therapeutic agents and photo(chemo)therapy is widely applied for the treatment of CTCL. The efficacy and safety of bexarotene and photo(chemo)therapy combination therapy were previously con...
Autores principales: | Morita, Akimichi, Tateishi, Chiharu, Ikumi, Kyoko, Hayashi, Daisuke, Nakada, Aya, Nishihara, Haruna, Torii, Kan, Nishida, Emi, Tsuruta, Daisuke |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Healthcare
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8941067/ https://www.ncbi.nlm.nih.gov/pubmed/35084694 http://dx.doi.org/10.1007/s13555-021-00655-0 |
Ejemplares similares
-
Efficacy and safety of bexarotene combined with photo(chemo)therapy for cutaneous T‐cell lymphoma
por: Morita, Akimichi, et al.
Publicado: (2020) -
Photo(chemo)therapy Reduces Circulating Th17 Cells and Restores Circulating Regulatory T Cells in Psoriasis
por: Furuhashi, Takuya, et al.
Publicado: (2013) -
A Novel Co-Crystal of Bexarotene and Ligustrazine Improves Pharmacokinetics and Tissue Distribution of Bexarotene in SD Rats
por: Ren, Shuyue, et al.
Publicado: (2020) -
Bexarotene Gel: A New Topical Therapy for Alopecia Areata
por: Rajiv, Mahajan, et al.
Publicado: (2010) -
Photodegradation of Bexarotene and Its Implication for Cytotoxicity
por: Kryczyk-Poprawa, Agata, et al.
Publicado: (2021)